KIRKLAND, QC, Jan. 22 /CNW/ - Pfizer Canada Inc. announced today that Health Canada has approved ZELDOX (ziprasidone hydrochloride), for use in the treatment of acute manic or mixed episodes ...

March 3, 2009 — The presence of manic symptoms coexisting with depression may predict treatment-emergent mania caused by antidepressant therapy, a small study suggests. Three manic symptoms in ...

The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...

Bipolar disorder exists on a spectrum rather than as a single, uniform condition. This fundamental characteristic explains why two people with the same diagnosis can experience dramatically different ...

Yesterday, I couldn’t stand being inside my skin. It felt like a prison, this body of mine that didn’t know what it wanted or why it was here. I squirmed through the day, fussing and eating and eating ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

An improvement in the ability to properly diagnose patients with mood disorders is an ongoing goal that is made both easier and more difficult (less simplistic) with an increased understanding of the ...

Schizoaffective bipolar disorder is a rare mental health condition that displays characteristics of bipolar disorder and schizophrenia.